The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2018 | Biostatistics: can we produce more valid results from trials?
The British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland, hosted sessions covering a diverse range of topics, inciting thought-provoking conversation. Here, speaking from the meeting, Keith Kerr, FRCPath, FRCPE, from the University of Aberdeen, Aberdeen, UK, discusses an interesting talk on statistical analysis, which the raised questions including whether past trial data should be reanalyzed and regarding the design of future clinical trials.
